All Exelixis Inc Sponsors for H1B Applications - 2021

Explore H1B salary data for top companies like Exelixis-inc across different cities for various job titles and discover the average salaries.

Company name
Job Title
City Name
Average Salary
Exelixis Inc Director Commercial Strategy Planning Alameda $ 195,277 / Year
Exelixis Inc Senior Clinical Trials Manager Alameda $ 173,138 / Year
Exelixis Inc Clinical Data Manager Ii Alameda $ 120,000 / Year
Exelixis Inc Senior Clinical Data Manager Alameda $ 140,000 / Year
Exelixis Inc Senior Statistical Programmer Ii Alameda $ 155,000 / Year
Exelixis Inc Sap Data Analyst Alameda $ 150,000 / Year
Exelixis Inc Clinical Data Manager Ii Alameda $ 120,000 / Year
Exelixis Inc Sr Director Commercial Strategy Planning Alameda $ 230,574 / Year
Exelixis Inc Senior Director Commercial Strategy Planning Alameda $ 230,574 / Year
Exelixis Inc Senior Formulations Scientist Ii Alameda $ 170,000 / Year
Exelixis Inc Senior Manager Sales Operations Alameda $ 159,723 / Year
Exelixis Inc Clinical Data Manager Ii Alameda $ 120,000 / Year
Exelixis Inc Senior Medical Science Liaison Alameda $ 207,400 / Year
Exelixis Inc Senior Market Planning Manager Alameda $ 157,000 / Year
Exelixis Inc Senior Statistical Programmer I Alameda $ 148,500 / Year
Exelixis Inc Senior Clinical Data Manager Alameda $ 145,000 / Year
Exelixis Inc Backend Engineer Alameda $ 145,205 / Year
Exelixis Inc Quantitative Analytics Forecasting Director Alameda $ 215,000 / Year
Exelixis Inc Director Release Engineering Alameda $ 220,518 / Year
Exelixis Inc Senior Scientist Ii Alameda $ 172,000 / Year

Last 5 Years H-1B Salary Data

h1bInfo.org is an independent website that displays public disclosure data in a user-friendly format. We have analyzed 10 years of H1B data from USCIS and the US Department of Labor, covering more than 6 million records from FY 2014 to FY 2023. However, for the latest and most accurate data, it's best to check the official sources directly. All content on H1BInfo is copyrighted and all rights are reserved from 2022 to 2023.